NVRO
Price:
$5.84
Market Cap:
$224.09M
Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products a...[Read more]
Industry
Medical - Devices
IPO Date
2014-11-06
Stock Exchange
NYSE
Ticker
NVRO
According to Nevro Corp.’s latest financial reports and current stock price. The company's current ROE is -43.28%. This represents a change of 285.97% compared to the average of -11.21% of the last 4 quarters.
The mean historical ROE of Nevro Corp. over the last ten years is -26.85%. The current -43.28% ROE has changed 61.23% with respect to the historical average. Over the past ten years (40 quarters), NVRO's ROE was at its highest in in the September 2022 quarter at 25.08%. The ROE was at its lowest in in the December 2024 quarter at -22.99%.
Average
-26.85%
Median
-25.06%
Minimum
-49.11%
Maximum
0.93%
Discovering the peaks and valleys of Nevro Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 139.10%
Maximum Annual ROE = 0.93%
Minimum Annual Increase = -3494.86%
Minimum Annual ROE = -49.11%
| Year | ROE | Change |
|---|---|---|
| 2024 | -49.11% | 56.11% |
| 2023 | -31.46% | -3494.86% |
| 2022 | 0.93% | -102.14% |
| 2021 | -43.27% | 102.33% |
| 2020 | -21.38% | -55.38% |
| 2019 | -47.92% | 139.10% |
| 2018 | -20.04% | 36.24% |
| 2017 | -14.71% | 15.29% |
| 2016 | -12.76% | -55.61% |
| 2015 | -28.74% | 61.21% |
The current ROE of Nevro Corp. (NVRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-26.55%
5-year avg
-28.86%
10-year avg
-26.85%
Nevro Corp.’s ROE is greater than Shineco, Inc. (-65.30%), greater than Second Sight Medical Products Inc (-264.04%), greater than Sonida Senior Living, Inc. (-35.37%), greater than BioSig Technologies, Inc. (-719.15%), greater than Alaunos Therapeutics, Inc. (-165.94%), greater than Acelyrin, Inc. (-31.03%), greater than CARGO Therapeutics, Inc. Common Stock (-61.29%), greater than Spectrum Pharmaceuticals, Inc. (-207.06%), greater than LakeShore Biopharma Co., Ltd (-18.43%), greater than Inozyme Pharma, Inc. (-122.99%),
| Company | ROE | Market cap |
|---|---|---|
| -65.30% | $79.10K | |
| -264.04% | $0 | |
| -35.37% | $719.16M | |
| -719.15% | $191.13M | |
| -165.94% | $5.25M | |
| -31.03% | $229.17M | |
| -61.29% | $216.19M | |
| -207.06% | $210.38M | |
| -18.43% | $25.84M | |
| -122.99% | $258.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nevro Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nevro Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nevro Corp.'s ROE?
How is the ROE calculated for Nevro Corp. (NVRO)?
What is the highest ROE for Nevro Corp. (NVRO)?
What is the 3-year average ROE for Nevro Corp. (NVRO)?
What is the 5-year average ROE for Nevro Corp. (NVRO)?
How does the current ROE for Nevro Corp. (NVRO) compare to its historical average?